New IDC MarketScape Evaluates Worldwide Life Science R&D BPO Vendors

FRAMINGHAM, Mass., December 19, 2013 – IDC Health Insights announced today the availability of a new IDC MarketScape report, "IDC MarketScape: Worldwide Life Science R&D BPO 2013 Vendor Assessment" (Document #244934), the first of a three-part life science R&D IDC MarketScape series.  The new report provides an assessment of where the life science R&D outsourcing market is going, how the major vendors compare with one another and what criteria are most important for life science companies to consider when selecting an IT outsourcing vendor. ClicktoTweet Vendors evaluated in this report include: Accenture, Cognizant Technology Solutions, CSC, HCL Technologies, Indegene, iGate, Syntel, Tata Consultancy Services (TCS), Tech Mahindra and Winpro.

BPO is a significant R&D growth area within the life science industry, based on the ongoing de-risking of processes across the life science life cycle. While initially focused in the areas of call centers, case processing, and clinical data management, BPO is expanding as previously defined core activities become better characterized and likely outcomes better defined. Key R&D areas where BPO is expanding include virtual IT infrastructure services, statistical modeling, drug safety signal detection, regulatory intelligence, and remote clinical data monitoring.

Of the estimated $14 billion worldwide IT outsourcing life science services market, BPO in the R&D space is expected to contribute more than $2.4 billion in 2013. IDC expects that the total IT services market will continue to grow at double-digit rates over the next five years, with an average annual growth rate of 12%. IT services outsourcing covers the entire life science R&D value chain, with offerings ranging from drug discovery to clinical drug development to drug safety to regulatory compliance and beyond.

According to the report, key attributes that life science companies are looking for in their service providers include:

Deep, proven life science-specific BPO capabilities

Understanding of the life science business at both company and tactical levels

Flexibility in resourcing on a global basis, including availability of onshore/onsite for some needs

The ability to effectively scale up engagements in a timely fashion and minimize the ongoing impact of attrition on project efforts

Practical understanding of when industry-agnostic knowledge is appropriate to life science BPO engagements

Strong referenceable clients

Alan Louie, research director of IDC Health Insights' clinical development, technology, and strategy research, noted, "BPO in the life sciences is growing rapidly as companies have determined that tasks like clinical data management and drug safety call centers can be competently outsourced to external service providers, yielding both operational agility and direct cost savings. While patient-centric tasks are increasingly outsourced to external CRO partners, data- and information-centric activities will likely remain under the domain of IT service providers, based on their superior pricing capabilities and the ability to leverage their cross-industry IT expertise with industry-specific knowledge. This bodes well for the life science R&D BPO IT vendor ecosystem, which should continue to grow over the foreseeable future."

IDC MarketScape criteria selection, weightings, and vendor scores represent well-researched IDC judgment about the market and specific vendors. IDC analysts tailor the range of standard characteristics by which vendors are measured through structured discussions, surveys, and interviews with market leaders, participants and end users. Market weightings are based on user interviews, buyer surveys and the input of a review board of IDC experts in each market. IDC analysts base individual vendor scores, and ultimately vendor positions within the IDC MarketScape, on detailed surveys and interviews with the vendors, publicly available information and end-user experiences in an effort to provide an accurate and consistent assessment of each vendor's characteristics, behavior and capability.

For additional information about this report or to arrange a one-on-one briefing with Alan S. Louie, Ph.D., please contact Sarah Murray at 781-378-2674 or Reports are available to qualified members of the media. For information on purchasing reports, contact; reporters should email

About IDC MarketScapes

IDC MarketScape vendor analysis model is designed to provide an overview of the competitive fitness of IT, telecommunications, or industry-specific suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT, telecommunications, or industry-specific vendors can be meaningfully compared. The framework also provides technology buyers with a transparent foundation to allow companies to independently compare the strengths and weaknesses of current and prospective vendors.

About IDC Health Insights

IDC Health Insights assists health businesses and IT leaders, as well as the suppliers who serve them, in making more effective technology decisions by providing accurate, timely, and insightful fact-based research and consulting services. Staffed by senior analysts with decades of industry experience, our global research analyzes and advises on business and technology issues facing the payer, provider and life sciences industries. International Data Corporation (IDC) is the premier global provider of market intelligence, advisory services, and events for the information technology market. IDC is a subsidiary of IDG, the world’s leading technology, media, research, and events company. For more information, please visit, email, or call 508-935-4445. Visit the IDC Health Insights Community at